Nuformix Plc (GB:NFX)
LSE:NFX
Holding GB:NFX?
Track your performance easily

Nuformix Plc (NFX) Share Price & Analysis

1 Followers

NFX Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

11.02%0.00%0.00%88.98%
11.02% Insiders
0.00% Other Institutional Investors
88.98% Public Companies and
Individual Investors

NFX FAQ

What was Nuformix Plc’s price range in the past 12 months?
Nuformix Plc lowest share price was 0.14p and its highest was 0.44p in the past 12 months.
    What is Nuformix Plc’s market cap?
    Currently, no data Available
    When is Nuformix Plc’s upcoming earnings report date?
    Nuformix Plc’s upcoming earnings report date is Dec 17, 2024 which is in 87 days.
      How were Nuformix Plc’s earnings last quarter?
      Currently, no data Available
      Is Nuformix Plc overvalued?
      According to Wall Street analysts Nuformix Plc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Nuformix Plc pay dividends?
        Nuformix Plc does not currently pay dividends.
        What is Nuformix Plc’s EPS estimate?
        Nuformix Plc’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Nuformix Plc have?
        Nuformix Plc has 819,309,400 shares outstanding.
          What happened to Nuformix Plc’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Nuformix Plc?
          Currently, no hedge funds are holding shares in GB:NFX
          ---

          Nuformix Plc Stock Smart Score

          10
          Unlock Smart Score
          1
          2
          3
          4
          5
          6
          7
          8
          9
          10

          Company Description

          Nuformix Plc

          Nuformix PLC is a pharmaceutical development company. It is focused on building value for shareholders through its activities in drug development and by out-licensing. The company uses cocrystal technology to re-engineer the crystalline form of known small molecule drugs. Its pipeline products include NXP001, NXP002, and NXP004.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          MaxCyte
          Avacta Group plc
          ConvaTec
          EKF Diagnostics Holdings
          Popular Stocks
          ---
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis